Willett Robert 4
4 · COGNEX CORP · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Cognex (CGNX) Director Robert Willett Exercises Options, Sells Shares
What Happened
Director Robert Willett exercised stock options on Feb 12, 2026 and immediately sold the resulting shares. He exercised 173,296 options at $38.39/share (cost $6,652,833) and sold those 173,296 shares at $58.39/share (proceeds $10,117,904). He also exercised 3,756 options at $39.44/share (cost $148,137) and sold those 3,756 shares at $58.39/share (proceeds $219,294). Combined, 177,052 shares were sold for total proceeds of $10,337,198 against exercise costs of $6,800,970 (net proceeds ≈ $3,536,228). These transactions were effected pursuant to a Rule 10b5‑1 trading plan.
Key Details
- Transaction date: 2026-02-12 (reported on Form 4 filed 2026-02-13; appears timely)
- Exercise prices: $38.39 (173,296 shares) and $39.44 (3,756 shares)
- Sale price: $58.39 for all sold shares
- Total shares sold: 177,052; total proceeds: $10,337,198
- Footnotes: trades executed under a 10b5‑1 trading plan (F1); reporting person is trustee/beneficiary of a trust and disclaims beneficial ownership except for pecuniary interest (F2)
- Shares owned after transaction: not specified in the provided filing details
Context
- This was effectively a cashless exercise: options were exercised and the resulting shares were sold the same day in the open market. Such transactions are commonly routine liquidity events rather than an express signal about company outlook.
- The 10b5‑1 plan note indicates the timing was preplanned and designed to avoid trading on nonpublic information.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-12$38.39/sh+173,296$6,652,833→ 173,296 total - Sale
Common Stock
[F1]2026-02-12$58.39/sh−173,296$10,117,904→ 0 total - Exercise/Conversion
Common Stock
[F1]2026-02-12$39.44/sh+3,756$148,137→ 3,756 total - Sale
Common Stock
[F1]2026-02-12$58.39/sh−3,756$219,294→ 0 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1]2026-02-12−173,296→ 0 totalExercise: $38.39From: 2018-02-21Exp: 2027-02-21→ Common Stock (173,296 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F1]2026-02-12−3,756→ 294,394 totalExercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (3,756 underlying)
- 15,804(indirect: By Trust)
Common Stock
[F2] - 193,201
Non-Qualified Stock Option (right to buy)
Exercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (193,201 underlying) - 233,484
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (233,484 underlying) - 180,000
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (180,000 underlying) - 180,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (180,000 underlying) - 90,000
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (90,000 underlying) - 185,254
Non-Qualified Stock Option (right to buy)
Exercise: $64.43From: 2023-02-22Exp: 2032-02-22→ Common Stock (185,254 underlying) - 123,521
Non-Qualified Stock Option (right to buy)
Exercise: $90.50From: 2022-02-16Exp: 2031-02-16→ Common Stock (123,521 underlying) - 70,824
Restricted Stock Unit
Exercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (70,824 underlying)
Footnotes (2)
- [F1]These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.